Data for patients enrolled in the trial were updated from early August 2024 to January 17th, 2025. All of the acute myeloid ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

At 16 years old, Tia Bee Stokes opened a letter that would change her future, telling her that in 10 to 15 years, she would ...

CUTTACK: Doctors at the clinical hematology department of SCB medical college and hospital here have successfully conducted ...

"Chris was the patient who made us forget how devastating this disease can be," said his doctors, calling him unforgettable.

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...

Cops for Kids with Cancer seeks to remove the financial burden for families impacted by a cancer diagnosis. This week they ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid ...